{"id":"https://openalex.org/W1964495173","doi":"https://doi.org/10.1097/cmr.0b013e3283471086","title":"Utility of 3-year torso computed tomography and head imaging in asymptomatic patients with high-risk melanoma","display_name":"Utility of 3-year torso computed tomography and head imaging in asymptomatic patients with high-risk melanoma","publication_year":2011,"publication_date":"2011-05-05","ids":{"openalex":"https://openalex.org/W1964495173","doi":"https://doi.org/10.1097/cmr.0b013e3283471086","mag":"1964495173","pmid":"https://pubmed.ncbi.nlm.nih.gov/21540750","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/3131441"},"language":"en","primary_location":{"id":"doi:10.1097/cmr.0b013e3283471086","doi":"https://doi.org/10.1097/cmr.0b013e3283471086","is_oa":false,"landing_page_url":"https://doi.org/10.1097/cmr.0b013e3283471086","pdf_url":null,"source":{"id":"https://openalex.org/S3207524","display_name":"Melanoma Research","issn_l":"0960-8931","issn":["0960-8931","1473-5636"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Melanoma Research","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/3131441","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5050730760","display_name":"E. R. DeRose","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1316535847","display_name":"Beth Israel Deaconess Medical Center","ror":"https://ror.org/04drvxt59","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316535847"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Erin R. DeRose","raw_affiliation_strings":["The Cutaneous Oncology Program, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA","Accepted March 16, 2011","Received January 11, 2011","e-mail: [email\u00a0protected]","fax: +1 617 632 9263"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Cutaneous Oncology Program, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA","institution_ids":["https://openalex.org/I1316535847"]},{"raw_affiliation_string":"Accepted March 16, 2011","institution_ids":[]},{"raw_affiliation_string":"Received January 11, 2011","institution_ids":[]},{"raw_affiliation_string":"e-mail: [email\u00a0protected]","institution_ids":[]},{"raw_affiliation_string":"fax: +1 617 632 9263","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025598993","display_name":"Alexander L. Pleet","orcid":"https://orcid.org/0000-0002-7508-665X","observed_orcids":["https://orcid.org/0000-0002-7508-665X"]},"institutions":[{"id":"https://openalex.org/I1316535847","display_name":"Beth Israel Deaconess Medical Center","ror":"https://ror.org/04drvxt59","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316535847"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Alexander Pleet","raw_affiliation_strings":["The Cutaneous Oncology Program, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA","Accepted March 16, 2011","Received January 11, 2011","e-mail: [email\u00a0protected]","fax: +1 617 632 9263"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Cutaneous Oncology Program, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA","institution_ids":["https://openalex.org/I1316535847"]},{"raw_affiliation_string":"Accepted March 16, 2011","institution_ids":[]},{"raw_affiliation_string":"Received January 11, 2011","institution_ids":[]},{"raw_affiliation_string":"e-mail: [email\u00a0protected]","institution_ids":[]},{"raw_affiliation_string":"fax: +1 617 632 9263","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100391894","display_name":"Wei Wang","orcid":"https://orcid.org/0000-0002-1710-0919","observed_orcids":["https://orcid.org/0000-0002-1710-0919"]},"institutions":[{"id":"https://openalex.org/I1316535847","display_name":"Beth Israel Deaconess Medical Center","ror":"https://ror.org/04drvxt59","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316535847"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Wei Wang","raw_affiliation_strings":["The Cutaneous Oncology Program, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA","Accepted March 16, 2011","Received January 11, 2011","e-mail: [email\u00a0protected]","fax: +1 617 632 9263"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Cutaneous Oncology Program, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA","institution_ids":["https://openalex.org/I1316535847"]},{"raw_affiliation_string":"Accepted March 16, 2011","institution_ids":[]},{"raw_affiliation_string":"Received January 11, 2011","institution_ids":[]},{"raw_affiliation_string":"e-mail: [email\u00a0protected]","institution_ids":[]},{"raw_affiliation_string":"fax: +1 617 632 9263","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5081174035","display_name":"Virginia Jean Seery","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1316535847","display_name":"Beth Israel Deaconess Medical Center","ror":"https://ror.org/04drvxt59","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316535847"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Virginia J. Seery","raw_affiliation_strings":["The Cutaneous Oncology Program, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA","Accepted March 16, 2011","Received January 11, 2011","e-mail: [email\u00a0protected]","fax: +1 617 632 9263"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Cutaneous Oncology Program, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA","institution_ids":["https://openalex.org/I1316535847"]},{"raw_affiliation_string":"Accepted March 16, 2011","institution_ids":[]},{"raw_affiliation_string":"Received January 11, 2011","institution_ids":[]},{"raw_affiliation_string":"e-mail: [email\u00a0protected]","institution_ids":[]},{"raw_affiliation_string":"fax: +1 617 632 9263","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109917216","display_name":"Mee Young Lee","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1316535847","display_name":"Beth Israel Deaconess Medical Center","ror":"https://ror.org/04drvxt59","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316535847"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mee Young Lee","raw_affiliation_strings":["The Cutaneous Oncology Program, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA","Accepted March 16, 2011","Received January 11, 2011","e-mail: [email\u00a0protected]","fax: +1 617 632 9263"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Cutaneous Oncology Program, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA","institution_ids":["https://openalex.org/I1316535847"]},{"raw_affiliation_string":"Accepted March 16, 2011","institution_ids":[]},{"raw_affiliation_string":"Received January 11, 2011","institution_ids":[]},{"raw_affiliation_string":"e-mail: [email\u00a0protected]","institution_ids":[]},{"raw_affiliation_string":"fax: +1 617 632 9263","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045308329","display_name":"Sharon Renzi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1316535847","display_name":"Beth Israel Deaconess Medical Center","ror":"https://ror.org/04drvxt59","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316535847"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sharon Renzi","raw_affiliation_strings":["The Cutaneous Oncology Program, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA","Accepted March 16, 2011","Received January 11, 2011","e-mail: [email\u00a0protected]","fax: +1 617 632 9263"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Cutaneous Oncology Program, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA","institution_ids":["https://openalex.org/I1316535847"]},{"raw_affiliation_string":"Accepted March 16, 2011","institution_ids":[]},{"raw_affiliation_string":"Received January 11, 2011","institution_ids":[]},{"raw_affiliation_string":"e-mail: [email\u00a0protected]","institution_ids":[]},{"raw_affiliation_string":"fax: +1 617 632 9263","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008479799","display_name":"Ryan Joseph Sullivan","orcid":"https://orcid.org/0000-0001-5344-6645","observed_orcids":["https://orcid.org/0000-0001-5344-6645"]},"institutions":[{"id":"https://openalex.org/I1316535847","display_name":"Beth Israel Deaconess Medical Center","ror":"https://ror.org/04drvxt59","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316535847"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ryan J. Sullivan","raw_affiliation_strings":["The Cutaneous Oncology Program, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA","Accepted March 16, 2011","Received January 11, 2011","e-mail: [email\u00a0protected]","fax: +1 617 632 9263"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Cutaneous Oncology Program, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA","institution_ids":["https://openalex.org/I1316535847"]},{"raw_affiliation_string":"Accepted March 16, 2011","institution_ids":[]},{"raw_affiliation_string":"Received January 11, 2011","institution_ids":[]},{"raw_affiliation_string":"e-mail: [email\u00a0protected]","institution_ids":[]},{"raw_affiliation_string":"fax: +1 617 632 9263","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5052526230","display_name":"Michael B. Atkins","orcid":"https://orcid.org/0000-0003-3901-9924","observed_orcids":["https://orcid.org/0000-0003-3901-9924"]},"institutions":[{"id":"https://openalex.org/I1316535847","display_name":"Beth Israel Deaconess Medical Center","ror":"https://ror.org/04drvxt59","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316535847"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Michael B. Atkins","raw_affiliation_strings":["The Cutaneous Oncology Program, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA","to Michael B. Atkins, MD, The Cutaneous Oncology Program, Beth Israel Deaconess Medical Center, 375 Longwood Ave., Boston, MA, USA Tel: +1 617 632 9250; fax: +1 617 632 9263; e-mail: [email\u00a0protected]","Accepted March 16, 2011","Received January 11, 2011","e-mail: [email\u00a0protected]","fax: +1 617 632 9263"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Cutaneous Oncology Program, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA","institution_ids":["https://openalex.org/I1316535847"]},{"raw_affiliation_string":"to Michael B. Atkins, MD, The Cutaneous Oncology Program, Beth Israel Deaconess Medical Center, 375 Longwood Ave., Boston, MA, USA Tel: +1 617 632 9250; fax: +1 617 632 9263; e-mail: [email\u00a0protected]","institution_ids":["https://openalex.org/I1316535847"]},{"raw_affiliation_string":"Accepted March 16, 2011","institution_ids":[]},{"raw_affiliation_string":"Received January 11, 2011","institution_ids":[]},{"raw_affiliation_string":"e-mail: [email\u00a0protected]","institution_ids":[]},{"raw_affiliation_string":"fax: +1 617 632 9263","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5052526230"],"corresponding_institution_ids":["https://openalex.org/I1316535847"],"apc_list":null,"apc_paid":null,"fwci":0.6295,"has_fulltext":false,"cited_by_count":11,"citation_normalized_percentile":{"value":0.70069523,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":97},"biblio":{"volume":"21","issue":"4","first_page":"364","last_page":"369"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10392","display_name":"Cutaneous Melanoma Detection and Management","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10392","display_name":"Cutaneous Melanoma Detection and Management","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10522","display_name":"Medical Imaging Techniques and Applications","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10202","display_name":"Lung Cancer Diagnosis and Treatment","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/melanoma","display_name":"melanoma","score":0.7419999837875366},{"id":"https://openalex.org/keywords/high-risk-melanoma","display_name":"high-risk melanoma","score":0.7459999918937683},{"id":"https://openalex.org/keywords/restaging-imaging","display_name":"restaging imaging","score":0.6940000057220459},{"id":"https://openalex.org/keywords/follow-up-strategy","display_name":"follow-up strategy","score":0.6240000128746033},{"id":"https://openalex.org/keywords/asymptomatic-patients","display_name":"asymptomatic patients","score":0.7300000190734863},{"id":"https://openalex.org/keywords/head-ct","display_name":"head CT","score":0.531000018119812},{"id":"https://openalex.org/keywords/head-mri","display_name":"head MRI","score":0.9539999961853027},{"id":"https://openalex.org/keywords/melanoma-recurrence","display_name":"melanoma recurrence","score":0.7889999747276306},{"id":"https://openalex.org/keywords/false-positive-imaging-findings","display_name":"false-positive imaging findings","score":0.6039999723434448},{"id":"https://openalex.org/keywords/cost-effectiveness","display_name":"cost-effectiveness","score":0.8209999799728394}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9406511187553406},{"id":"https://openalex.org/C2777910003","wikidata":"https://www.wikidata.org/wiki/Q1707292","display_name":"Asymptomatic","level":2,"score":0.8187547922134399},{"id":"https://openalex.org/C523889960","wikidata":"https://www.wikidata.org/wiki/Q160695","display_name":"Torso","level":2,"score":0.694347620010376},{"id":"https://openalex.org/C146357865","wikidata":"https://www.wikidata.org/wiki/Q1123245","display_name":"Stage (stratigraphy)","level":2,"score":0.6305036544799805},{"id":"https://openalex.org/C126838900","wikidata":"https://www.wikidata.org/wiki/Q77604","display_name":"Radiology","level":1,"score":0.5989294648170471},{"id":"https://openalex.org/C167135981","wikidata":"https://www.wikidata.org/wiki/Q2146302","display_name":"Retrospective cohort study","level":2,"score":0.5478082895278931},{"id":"https://openalex.org/C2777658100","wikidata":"https://www.wikidata.org/wiki/Q180614","display_name":"Melanoma","level":2,"score":0.5477527976036072},{"id":"https://openalex.org/C44249647","wikidata":"https://www.wikidata.org/wiki/Q208498","display_name":"Confidence interval","level":2,"score":0.4808248281478882},{"id":"https://openalex.org/C190892606","wikidata":"https://www.wikidata.org/wiki/Q3512464","display_name":"Radiological weapon","level":2,"score":0.4156595766544342},{"id":"https://openalex.org/C2989005","wikidata":"https://www.wikidata.org/wiki/Q214963","display_name":"Nuclear medicine","level":1,"score":0.3481445908546448},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.3231264352798462},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.17918622493743896},{"id":"https://openalex.org/C105702510","wikidata":"https://www.wikidata.org/wiki/Q514","display_name":"Anatomy","level":1,"score":0.0},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.0},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.0},{"id":"https://openalex.org/C151730666","wikidata":"https://www.wikidata.org/wiki/Q7205","display_name":"Paleontology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000369","descriptor_name":"Aged, 80 and over","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001900","descriptor_name":"Boston","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003362","descriptor_name":"Cost-Benefit Analysis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005188","descriptor_name":"False Negative Reactions","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005189","descriptor_name":"False Positive Reactions","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006258","descriptor_name":"Head and Neck Neoplasms","qualifier_ui":"Q000000981","qualifier_name":"diagnostic imaging","is_major_topic":true},{"descriptor_ui":"D006258","descriptor_name":"Head and Neck Neoplasms","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":false},{"descriptor_ui":"D006258","descriptor_name":"Head and Neck Neoplasms","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008545","descriptor_name":"Melanoma","qualifier_ui":"Q000000981","qualifier_name":"diagnostic imaging","is_major_topic":true},{"descriptor_ui":"D008545","descriptor_name":"Melanoma","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":false},{"descriptor_ui":"D008545","descriptor_name":"Melanoma","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009367","descriptor_name":"Neoplasm Staging","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011237","descriptor_name":"Predictive Value of Tests","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012189","descriptor_name":"Retrospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012307","descriptor_name":"Risk Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013997","descriptor_name":"Time Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014057","descriptor_name":"Tomography, X-Ray Computed","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":true},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017721","descriptor_name":"Hospital Costs","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018570","descriptor_name":"Risk Assessment","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018572","descriptor_name":"Disease-Free Survival","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D053208","descriptor_name":"Kaplan-Meier Estimate","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D055815","descriptor_name":"Young Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.1097/cmr.0b013e3283471086","doi":"https://doi.org/10.1097/cmr.0b013e3283471086","is_oa":false,"landing_page_url":"https://doi.org/10.1097/cmr.0b013e3283471086","pdf_url":null,"source":{"id":"https://openalex.org/S3207524","display_name":"Melanoma Research","issn_l":"0960-8931","issn":["0960-8931","1473-5636"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Melanoma Research","raw_type":"journal-article"},{"id":"pmid:21540750","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/21540750","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Melanoma research","raw_type":"Evaluation Study"},{"id":"pmh:oai:europepmc.org:2411488","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/3131441","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":null,"raw_type":"Text"},{"id":"pmh:oai:pubmedcentral.nih.gov:3131441","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/3131441","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"Melanoma Res","raw_type":"Text"}],"best_oa_location":{"id":"pmh:oai:europepmc.org:2411488","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/3131441","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":null,"raw_type":"Text"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9922999739646912,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[{"id":"https://openalex.org/G9000334428","display_name":"SPORE in Skin Cancer","funder_award_id":"P50CA093683","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"}],"funders":[{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":17,"referenced_works":["https://openalex.org/W1828940258","https://openalex.org/W1908752382","https://openalex.org/W1919080085","https://openalex.org/W1966737793","https://openalex.org/W1988375101","https://openalex.org/W1995616737","https://openalex.org/W1998445815","https://openalex.org/W2001453392","https://openalex.org/W2021786774","https://openalex.org/W2035323182","https://openalex.org/W2037432304","https://openalex.org/W2059569231","https://openalex.org/W2064732819","https://openalex.org/W2071868318","https://openalex.org/W2136421130","https://openalex.org/W2143323496","https://openalex.org/W2186181785"],"related_works":["https://openalex.org/W2528563790","https://openalex.org/W2806060808","https://openalex.org/W3097301740","https://openalex.org/W3183451999","https://openalex.org/W1988375101","https://openalex.org/W1966737793","https://openalex.org/W2055609933","https://openalex.org/W2095907493","https://openalex.org/W1988522331","https://openalex.org/W4213268952"],"abstract_inverted_index":{"There":[0],"is":[1,217],"no":[2],"general":[3],"consensus":[4],"regarding":[5],"the":[6,18,33,51,112,208],"optimal":[7],"follow-up":[8,35],"strategy":[9],"for":[10,196],"patients":[11,27,43,70,120,142,201],"with":[12,28,45,145,202],"melanoma.":[13,205],"We":[14],"sought":[15],"to":[16,130,191],"determine":[17],"utility":[19],"and":[20,64,73,77,86,106,111,155,165,198],"cost":[21,113,181],"effectiveness":[22],"of":[23,26,41,94,99,119,141,193,211],"radiological":[24],"restaging":[25,79,188],"stage":[29,46,203],"IIB-IIIC":[30,47,204],"melanoma":[31,48,122],"at":[32,55],"3-year":[34,187],"time":[36,129],"point.":[37],"A":[38],"retrospective":[39],"review":[40],"210":[42],"diagnosed":[44],"seen":[49],"in":[50],"Cutaneous":[52],"Oncology":[53],"Program":[54],"Beth":[56],"Israel":[57],"Deaconess":[58],"Medical":[59],"Center":[60],"between":[61],"January,":[62],"2001":[63],"July,":[65],"2006":[66],"was":[67,184],"conducted.":[68],"Fifty-two":[69],"were":[71,109,159,177],"asymptomatic":[72],"continuously":[74,199],"disease":[75,146],"free":[76],"underwent":[78],"head":[80,149,153,163],"computed":[81],"tomography":[82],"(CT)":[83],"or":[84,97],"MRI":[85],"torso":[87,157,168],"CT":[88,150,164,169],"scans":[89,108,170],"3":[90,126,214],"years":[91,127],"after":[92],"completion":[93],"local-regional":[95],"therapy":[96],"initiation":[98],"adjuvant":[100],"treatment.":[101],"True":[102],"positive,":[103,173],"false":[104,172],"positive":[105],"normal":[107],"identified":[110],"per":[114,182],"diagnosis":[115,183],"calculated.":[116],"Fifty-five":[117],"percent":[118],"developed":[121],"recurrences:":[123],"88%":[124],"before":[125],"(median":[128],"recurrence":[131,212],"12":[132],"months,":[133],"95%":[134],"confidence":[135],"interval:":[136],"10-16":[137],"months).":[138],"The":[139,179],"majority":[140],"(69%)":[143],"recurred":[144],"symptoms.":[147],"Twenty-five":[148],"scans,":[151],"27":[152],"MRIs,":[154],"52":[156],"CTs":[158],"performed.":[160],"One":[161],"false-positive":[162],"five":[166],"abnormal":[167],"(three":[171],"two":[174],"true":[175],"positive)":[176],"identified.":[178],"total":[180],"$312,990.":[185],"Extensive":[186],"imaging":[189,222],"seems":[190],"be":[192],"limited":[194],"value":[195],"symptomatic":[197],"disease-free":[200],"Furthermore,":[206],"given":[207],"low":[209,226],"risk":[210],"beyond":[213],"years,":[215],"it":[216],"likely":[218],"that":[219],"subsequent":[220],"routine":[221],"would":[223],"have":[224],"similarly":[225],"utility.":[227]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":1},{"year":2017,"cited_by_count":2},{"year":2013,"cited_by_count":3},{"year":2012,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}